REDEFINING MONOCLONAL ANTIBODY THERAPY
DEAD

Serial Number

76604657

Owner

IMCLONE SYSTEMS INCORPORATED

Attorney

ROBERT M. KUNSTADT

Filing Date

Jul 21, 2004

Add to watchlist:

No watchlists yet
View on USPTO

REDEFINING MONOCLONAL ANTIBODY THERAPY Trademark

Serial Number: 76604657

REDEFINING MONOCLONAL ANTIBODY THERAPY is a trademark filed by IMCLONE SYSTEMS INCORPORATED on July 21, 2004. The trademark is classified under Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

IMCLONE SYSTEMS INCORPORATED (60 trademarks)

NEW YORK, NY 10014

Entity Type: 03

Trademark Details

Filing Date

July 21, 2004

Registration Date

Not Registered

Published for Opposition

October 4, 2005

Goods & Services

MEDICAL INFORMATION SERVICES RENDERED TO THE PUBLIC BY MEANS OF A GLOBAL COMPUTER INFORMATION NETWORK, PERTAINING TO CANCER, CANCER RESEARCH, TREATMENT OF CANCER, PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CANCER, VACCINES AND DIAGNOSTIC PREPARATIONS

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Aug 28, 2006 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 28, 2006 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 27, 2005 NOAM
PUBLISHED FOR OPPOSITION
Oct 4, 2005 PUBO
NOTICE OF PUBLICATION
Sep 14, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 8, 2005 PREV
ASSIGNED TO LIE
Aug 5, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2005 CNSA
AMENDMENT FROM APPLICANT ENTERED
Jul 26, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2005 CRFA
PAPER RECEIVED
Jul 14, 2005 MAIL
PRIORITY ACTION MAILED
Feb 24, 2005 CPRA
PRIORITY ACTION WRITTEN
Feb 23, 2005 CPRA
ASSIGNED TO EXAMINER
Feb 23, 2005 DOCK
PAPER RECEIVED
Feb 7, 2005 MAIL
NEW APPLICATION ENTERED
Aug 9, 2004 NWAP